{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:02:19Z","timestamp":1790870539868,"version":"4.1.0"},"reference-count":0,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[1995,7,1]],"date-time":"1995-07-01T00:00:00Z","timestamp":804556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[1995,7]]},"abstract":"<jats:p>Epstein-Barr virus (EBV) causes various diseases, such as infectious mononucleosis (IM), fatal IM, EBV-associated hemophagocytic syndrome (EBVAHS), and chronic active EBV infection (CAEBV). In the present study, cell-free EBV DNA was detected in the plasma of patients with EBV-associated diseases by PCR assay. The patients included 20 patients with IM, 2 patients with fatal IM, 4 patients with EBVAHS, 4 patients with CAEBV, and 38 healthy children (20 EBV seropositive and 18 EBV seronegative). In patients with IM, plasma samples were positive for EBV DNA in all patients (100%) in the acute phase and in 44% of the patients in the convalescent phase, but plasma samples from the 38 healthy control children were negative (0%) for EBV DNA. Quantitative PCR assay revealed that plasma from patients with IM contained the highest amount of virus DNA within 7 days following the onset of disease (mean, 6 x 10(4) copies per ml). The EBV DNA concentration decreased thereafter as the patients recovered. Plasma from patients with fatal IM contained more than 100 times more copies of EBV DNA (3 x 10(7) copies per ml) than plasma from patients with IM. Plasma from patients with the acute phase of EBVAHS contained 10 times more copies of EBV DNA (5 x 10(5) copies per ml) than plasma from IM, and then patients with the number of copies decreased similarly in both groups of patients in the convalescent phase (2 x 10(4) copies per ml). The amount of virus DNA in patients with CAEBV (6 x 10(4) copies per ml) was similar to that noted in patients with IM; however, it became higher (1 x 10(6) copies per ml) when the patients' clinical status deteriorated. These data suggest that the presence of cell-free EBV DNA in plasma is a common phenomenon in patients with EBV-associated diseases. The concentration of EBV DNA in plasma seems to be higher in patients with the more severe clinical categories of EBV diseases.<\/jats:p>","DOI":"10.1128\/jcm.33.7.1765-1768.1995","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T15:58:12Z","timestamp":1578326292000},"page":"1765-1768","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":106,"title":["Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases"],"prefix":"10.1128","volume":"33","author":[{"given":"M","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Nagoya University School of Medicine, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University School of Medicine, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Hironaka","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University School of Medicine, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Hirai","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University School of Medicine, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University School of Medicine, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kuzushima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University School of Medicine, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University School of Medicine, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Morishima","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University School of Medicine, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.33.7.1765-1768.1995","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.33.7.1765-1768.1995","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T02:33:59Z","timestamp":1646447639000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jcm.33.7.1765-1768.1995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1995,7]]}},"alternative-id":["10.1128\/jcm.33.7.1765-1768.1995"],"URL":"https:\/\/doi.org\/10.1128\/jcm.33.7.1765-1768.1995","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,7]]},"assertion":[{"value":"1995-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}